Experimental cell therapy tested for Tough-to-Treat blood cancer
Disease control
Terminated
This study tested a type of immunotherapy called CAR-T for patients with multiple myeloma that had returned or stopped responding to other treatments. The goal was to see if this personalized cell therapy was safe and could help control the cancer. The trial was very small and en…
Phase: NA • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC